CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-09 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +725,000 | 725,000 | ||
| 2021-09-09 | Hashim Mir Chief Scientific Officer | Grant or award | +117,600 | 117,600 | ||
| 2021-08-03 | Quiroga Moreno Isidoro 10% owner | Purchase | +2,727,273 | $11.00 | $30.0M | 8,158,927 |
| 2021-08-03 | Quiroga Moreno Isidoro 10% owner | Purchase | +3,572,727 | $11.00 | $39.3M | 11,731,654 |
| 2021-07-30 | Quiroga Moreno Isidoro 10% owner | Purchase | +158,904 | $11.25 | $1.8M | 5,431,654 |
Page 15 of 15 · 285 trades